Clinical Trial Update: Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Noni extract in men with very low or low risk prostate cancer has been terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Noni extract

Snippet

Sponsor: University of Hawaii | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2021-11-26